Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Treace Medical Concepts
TMCI
Treace Medical Concepts
Aging Population Will Drive Lapiplasty Adoption And Bunion Procedure Growth
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 6 Analysts
Published
07 Aug 25
Updated
07 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$14.50
57.7% undervalued
intrinsic discount
07 Aug
US$6.13
Loading
1Y
7.7%
7D
9.3%
Author's Valuation
US$14.5
57.7% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$14.5
57.7% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-64m
286m
2019
2021
2023
2025
2027
2028
Revenue US$285.5m
Earnings US$35.2m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
9.03%
Medical Equipment revenue growth rate
0.31%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.87%
Calculation
US$35.25m
Earnings '28
x
33.60x
PE Ratio '28
=
US$1.18b
Market Cap '28
US$1.18b
Market Cap '28
/
65.10m
No. shares '28
=
US$18.19
Share Price '28
US$18.19
Share Price '28
Discounted to 2025 @ 7.91% p.a.
=
US$14.48
Fair Value '25